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Crystal Structure of a Polymeric
Immunoglobulin Binding Fragment
of the Human Polymeric Immunoglobulin Receptor
containing pIgs secreted by local plasma cells (Brandt-
zaeg and Prydz, 1984; Radl et al., 1971; Vaerman et al.,
1998a). Human pIgR binds and transports both dIgA and
pIgM, whereas pIgRs from other species (e.g., rabbit,
rodents, and chicken) only bind dIgA (Socken and Un-
Agnes E. Hamburger,1,3 Anthony P. West, Jr.,1
and Pamela J. Bjorkman1,2,*
1Division of Biology 114-96
2 Howard Hughes Medical Institute
California Institute of Technology
Pasadena, California 91125 derdown, 1978; Underdown et al., 1992; Wieland et al.,
2004). Biochemical and mutagenesis studies revealed3 Division of Biology
Massachusetts Institute of Technology that pIgR binding to dIgA takes place in two steps. First,
the N-terminal pIgR domain (D1) makes a noncovalentCambridge, Massachusetts 02142
interaction with the C3, and possibly C2, domains of
one of the Fc regions of dIgA (Frutiger et al., 1986; Gen-
este et al., 1986; Hexham et al., 1999). In the secondSummary
step, Cys467 in the C-terminal domain of the extracellu-
lar portion of human pIgR (D5) makes a disulfide bondThe polymeric immunoglobulin receptor (pIgR) is a
with Cys311 in the C2 domain of the second IgA mole-type I transmembrane protein that delivers dimeric
cule (Fallgreen-Gebauer et al., 1993). pIgR/pIg com-IgA (dIgA) and pentameric IgM to mucosal secretions.
plexes are transcytosed to the apical surface of theHere, we report the 1.9 A˚ resolution X-ray crystal struc-
epithelial monolayer, where the pIgR/pIg complex is re-ture of the N-terminal domain of human pIgR, which
leased from the membrane by the proteolytic cleavagebinds dIgA in the absence of other pIgR domains with
of pIgR, forming secretory Ig (SIg). The cleaved ectodo-an equilibrium dissociation constant of 300 nM. The
main of human pIgR, also known as secretory compo-structure of pIgR domain 1 reveals a folding topology
nent (SC), is covalently attached via a disulfide bondsimilar to immunoglobulin variable domains, but with
to dIgA or noncovalently to pIgM (Brandtzaeg, 1975;differences in the counterparts of the complementarity
Mostov et al., 1980). Free SC that is not complexed todetermining regions (CDRs), including a helical turn in
a pIg is also released into secretions (Brandtzaeg, 1973).CDR1 and a CDR3 loop that points away from the
pIgR is a glycosylated type I transmembrane protein,other CDRs. The unusual CDR3 loop position prevents
consisting of a 620 residue extracellular region, a 23dimerization analogous to the pairing of antibody vari-
residue transmembrane region, and a 103 residue cyto-able heavy and variable light domains. The pIgR do-
plasmic tail. The extracellular region contains five do-main 1 structure allows interpretation of previous mu-
mains (domains 1–5; D1–D5) that share sequence simi-tagenesis results and structure-based comparisons
larity with Ig variable (V) regions (Mostov et al., 1984).between pIgR and other IgA receptors.
Thus, the pIgR D1-D5 domains are predicted to be 
sandwich structures each containing two sheets (com-
Introduction posed of strands A, B, E, and D and strands C″, C, C,
F, G, and A in the case of D1–D4, and strands A, B, E,
Polymeric immunoglobulins (pIgs) at mucosal surfaces D and strands A, C, F, and G in the case of D5). D1–D4
provide the first line of defense against pathogens and each contain regions homologous to the three anti-
toxins. Polymeric IgA (mainly dimeric IgA; dIgA) is the gen binding complementarity-determining region (CDR)
predominant Ig found in secretions, with pentameric IgM loops of Ig variable domains.
(pIgM) present at lower levels (Norderhaug et al., 1999b). Mutagenesis and peptide binding studies have identi-
Unlike other antibody isotypes, IgA and IgM can form fied probable binding sites on pIgR and dIgA. pIgR D1
polymers via an 18-residue extension at their C termini is necessary and sufficient for binding to dIgA (Frutiger
called the tailpiece. The joining (J) chain, a 15 kDa poly- et al., 1986) and all three of its CDR loops have been
peptide, promotes the oligomerization of IgA and IgM implicated in the interaction with the antibody (Coyne
to form pIgs by crosslinking the homodimeric Fc regions et al., 1994). Potential pIgR binding sites on dIgA involve
of two or five antibody molecules, respectively (Halpern the dIgA C3 domain and include residues 402–410 in
and Koshland, 1970; Mestecky et al., 1971). In dIgA, the loop connecting strands D and E and residues 430–
J-chain forms two intermolecular disulfide bonds, the 443 in the FG loop (Hexham et al., 1999; White and
first with one of two tailpieces in the first Fc homodimer Capra, 2002). Since pIgR preferentially binds and trans-
and the second with a tailpiece from the second Fc cytoses dIgA molecules containing J-chain, pIgR D1
homodimer. The two IgA heavy chains that are not cova- may also directly interact with J-chain (Brandtzaeg and
lently attached to J-chain form a disulfide bond to each Prydz, 1984; Vaerman et al., 1998a, 1998b). In order to
other via Cys471 in their tailpieces (Bastian et al., 1992). contribute to the molecular description of the interaction
The polymeric immunoglobulin receptor (pIgR) trans- between pIgR and pIgs, we determined the 1.9 A˚ crystal
ports pIgs across mucosal epithelia into mucosal secre- structure of a pIg binding fragment of the human pIgR
tions. pIgR is expressed on the basolateral surface of consisting of the N-terminal or D1 domain. The structure
epithelial cells, where it binds selectively to J-chain- reveals an Ig variable-like domain that allows interpreta-
tion of previous mutagenesis studies and comparison
with other IgA receptors.*Correspondence: bjorkman@caltech.edu
Structure
1926
Figure 1. Biosensor Analyses of pIgR D1
Binding to dIgA
(A) Equilibrium binding data for biosensor
experiments in which nonglycosylated (ex-
pressed in bacteria) and glycosylated (ex-
pressed in insect cells) versions of pIgR D1
were injected over dIgA immobilized at three
different densities (412, 763, and 1426 RUs).
The plot shows the equilibrium binding re-
sponse (Req) versus the log of concentration
of the indicated proteins. Best-fit binding
curves based on a 1:1 binding model are su-
perimposed on the binding data.
(B) Sensorgram from binding experiments in
which 5 M glycosylated or nonglycosylated
forms of D1 were injected over monomeric
(with and without the tailpiece) and dimeric
versions of the IgA Fc region. The injected
protein is indicated in front of an arrow point-
ing to the immobilized protein.
Results and Discussion Structure of pIgR D1
The 1.9 A˚ crystal structure of the human pIgR D1 was
solved by multiple isomorphous replacement withBiosensor Binding Experiments
The ligand binding domain of human pIgR, an Fc recep- anomalous scattering (MIRAS). As predicted by se-
quence analysis, the folding topology of pIgR D1 resem-tor that is specific for dimeric and polymeric forms of
IgA and IgM, was expressed in E. coli and refolded from bles the topologies of Ig variable heavy (VH) and variable
light (VL) domains (Mostov et al., 1984). Like Ig variableinclusion bodies. A glycosylated form of the protein was
also expressed in baculovirus-infected insect cells. D1 domains, pIgR D1 contains ten  strands assembled
into two antiparallel  sheets with strands A, B, E, andwas tested for binding to dimeric and monomeric ver-
sions of the IgA Fc region. For the dimeric version of IgA, D on one face and C″, C, C, F, G, and A on the other
(Figures 2A–2C). Five residues that are characteristic ofwe used dIgA/J-chain complexes purified from human
serum (Vaerman et al., 1995), and for the monomeric Ig regions (Williams and Barclay, 1988) are found in the
expected positions in pIgR D1: Cys22 and Cys92, whichversion, we used recombinant IgA Fc regions expressed
in CHO cells. One Fc region was expressed without the form a disulfide bond linking the two  sheets, Trp37,
the “invariant” tryptophan (Figure 2D) that packs intotailpiece (Fc) as described (Herr et al., 2003b), and the
other Fc region included the tailpiece (Fc-tp). Binding the hydrophobic core, and Arg63 and Asp86, which form
a salt bridge (Figure 3). In addition, pIgR D1 contains awas evaluated using a surface plasmon resonance-
based binding assay. Both the glycosylated and nongly- second disulfide bond between Cys38 and Cys46 that
link the C and C strands, which is also found in NKp44,cosylated forms of D1 bind to dIgA with an equilibrium
dissociation constant (KD) of 300 nM (Figure 1A), con- a natural killer cell cytotoxicity activating receptor (Can-
toni et al., 2003).sistent with other binding studies (Bakos et al., 1994).
Both versions of D1 show greatly reduced or negligible Antibody VH and VL domains each contain three hy-
pervariable complementarity-determining region (CDR)binding to the monomeric Fc and Fc-tp proteins at
concentrations up to 5 M (Figure 1B). By contrast, loops (CDR1, CDR2, and CDR3), which together form
the antigen combining site in a VH-VL heterodimer (Alzarianother IgA Fc receptor, FcRI, binds dIgA, Fc-tp, and
Fc when injected at a concentration of 5 M (data not et al., 1988). Although the pIgR D1 structure closely
resembles an isolated Ig variable domain, the positionsshown) (Herr et al., 2003b).
Structure of a pIg Binding Fragment of pIgR
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Figure 2. The Structure of Human pIgR D1
(A) C trace (molecule E). The 6His tag from molecule A (dashed line) was superimposed onto molecule E.
(B) Ribbon diagram showing side and front views of pIgR D1.  strands A, B, E, and D are shown in blue,  strands C″, C, C, F, G, and A
are in green, and the three CDR loops (including the  helix within CDR1) are red. Cysteines involved in disulfide bonds are shown in yellow
in ball-and-stick representation and the locations of potential N-linked glycosylation sites are indicated by pink spheres.
(C) Topology diagram of pIgR D1. The color schemes for the  strands,  helix, and CDR loops are the same as in (A).
(D) Stereoview of the pIgR D1 model in the region of the “invariant” tryptophan, Trp37, superimposed on a 2.7 A˚ experimental electron density
map (calculated with MIRAS phases) contoured at 1.0 .
of the three CDR loops in D1 differ substantially from are composed of extended structures joined by short
links or hairpin turns (Chothia et al., 1989). CDR2 andtheir antibody counterparts. Comparative analyses of
the CDR regions in antibody structures have allowed CDR3 in pIgR D1 do not appear to resemble any of
the canonical sequence or structure patterns. The pIgRclassification of CDR loops into a set of canonical struc-
tures (Chothia and Lesk, 1987). Although the sequence CDR2 loop is very short, with only two residues in the
loop region between the C and C″ strands. By contrast,of the D1 CDR1 loop shares similarity with sequences
found in type 1 of the six canonical CDR1 structures in CDR2 loops in V domains consist of three residues
that form a classic  turn (Al-Lazikani et al., 1997). UnlikeIg V domains (Bakos et al., 1993), the CDR1 structure in
pIgR D1 differs considerably. Unlike any of the canonical its position in antibody VH and VL domains, the CDR3
loop of pIgR D1 is tilted toward the C″CCFGA sheet,structures for CDR1 loops in VL or VH domains (Al-Lazi-
kani et al., 1997), the pIgR D1 CDR1 includes a single away from the other CDRs (Figure 4A). A conserved
hydrophobic residue, Tyr36, is buried at the interface ofhelical turn composed of residues that are highly con-
served among sequences of pIgR from different species the D1 CDR3 and the C″CCFGA sheet (Figure 4B). The
position of the CDR3 loop is stabilized by hydrogen(Figure 3). By contrast, CDR1 loops in VH and VL domains
Structure
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Figure 3. Amino Acid Sequence Alignment of Human pIgR D1 and Related Proteins
Top: pIgR D1 from eight different species and the Ig-like domain from the human Fc/R were aligned. Cysteines involved in disulfide bonds
are shown in red, conserved residues are highlighted in yellow, and conservatively substituted residues are highlighted in blue. Asterisks
indicate the positions of five characteristic residues in Ig V domains. Sequences within the three CDR loops are shown in bold and underlined.
Crystallographically determined secondary structure elements are shown above the sequences. Accession codes for the pIgR sequences
are: P01833 (human), P01832 (rabbit), O70570 (mouse), P15083 (rat), P81265 (bovine), AAK69593 (Macropus eugenii [tammar wallaby]),
AAD41688 (Trichosurus vulpecula [silver-gray brushtail possum]), and AAP69598 (Gallus gallus [chicken]), and AAL51154 (human Fc/R).
Bottom: the D1 domain of pIgR is aligned with the other domains within the human pIgR extracellular region.
bonds between Asn97 within the loop and two residues is released from the apical surface at low levels (Matsu-
moto et al., 2003). In addition, carbohydrates on SCon the C″CCFGA sheet: Arg34 in the C strand and
Thr48 in the C strand. The observed conformation of contribute to stabilization of SIgs by protecting it from
proteolytic degradation (Crottet and Corthesy, 1998).the D1 CDR3 loop is likely to represent its conformation
in solution because the loop is not involved in crystal
contacts. The different orientation of the pIgR CDR3 Structure-Based Interpretations
of Binding Studiesloop as compared to the CDR3 loops of Ig V domains
(Figure 4A) is consistent with why D1 does not form Previous mutational and peptide-mapping experiments
to define the regions of pIgR that form the binding sitesdimers analogous to antibody VH-VL heterodimers (Fig-
ure 4C) or VL-VL homodimers. When pIgR D1 is superim- for dIgA and pIgM can now be interpreted using the
pIgR D1 structure. CDR1 of pIgR D1 was proposed toposed on an Ig VH-VL combining site (Zdanov et al., 1994)
(Figure 4C) to create a D1 dimer, the CDR3 regions clash make essential contacts with dIgA because it is the most
highly conserved region of D1 among different specieswith the CC loop from the partner molecule (Figure 4D).
Although two different dimers of pIgR D1 are observed of pIgR, and a synthetic peptide corresponding to resi-
dues 15–37 of SC, a region that contains the D1 CDR1in the crystal packing, neither is analogous to Ig VH-VL
dimers. The D1 dimers in the crystals are unlikely to loop, is capable of binding pIgs (Bakos et al., 1991).
Interestingly, this peptide binds Igs indiscriminately, in-be biologically relevant because there are two different
dimeric arrangements and the D1 protein migrates in teracting with pIgs as well as with monomeric IgA and
IgG (Bakos et al., 1991). The promiscuous binding ofthe position expected for a monomer on a gel filtration
column (data not shown). this peptide suggests that other parts of D1, in addition
to the CDR1 loop, likely contribute to pIg binding speci-Although the protein used for our structural studies
is not glycosylated because it was expressed in bacte- ficity. The D1 structure reveals a solvent-exposed helix
within the CDR1 loop containing residues with the po-ria, the pIgR D1 structure can be used to locate residues
to which carbohydrate would normally be attached. Hu- tential to make direct contacts with pIgs (Figure 5).
Point mutations in the CDR1 region of the rabbit pIgRman pIgR D1 contains two N-linked carbohydrates
attached to Asn65 and Asn72 (Hughes et al., 1999). D1 highlighted the importance of three charged residues
(two arginines and a lysine, which correspond to Arg31,These residues are located on the D strand and the DE
loop, respectively, and their sidechains are accessible Arg34, and Lys35 in the sequence of human pIgR D1).
Substitution of these residues with alanine abolishedto solvent (Figure 2B). Studies comparing the binding
of bacterially expressed nonglycosylated D1 with glyco- pIgR binding to dIgA (Coyne et al., 1994). The human
pIgR D1 structure shows that Arg31 (rabbit Arg37) issylated D1 expressed in insect cells revealed nearly
identical binding affinities for dIgA (Figure 1A), consis- solvent exposed and could interact directly with dIgA.
Although Arg34 and Lys35 were predicted to be in thetent with earlier studies showing that pIgR glycosylation
is not necessary for specific binding to dIgA (Bakos et CDR1 loop (Coyne et al., 1994), an analysis of main chain
hydrogen bonds in the D1 structure shows that they areal., 1991). Carbohydrates may be required, however, for
efficient transport or release of the pIgR ectodomain both in the C strand. Arg34 is the first residue in the
strand, as its main chain carbonyl group forms a hydro-during transcytosis of dIgA, since nonglycosylated pIgR
Structure of a pIg Binding Fragment of pIgR
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Figure 4. Structural Consequences of the Position of the pIgR D1 CDR3 Loop
(A) Stereoview of the superposition of pIgR D1 (red) with an Ig VL domain (blue) derived from a mouse single-chain Fv (PDB code 1MFA).
(B) Stereoview of the region in the vicinity of the pIgR D1 CDR3 loop showing Tyr36 buried at the interface between CDR3 and the C″CCFGA
sheet. A ball-and-stick representation of Tyr36 is shown in red. Atoms in residues that stabilize this position of CDR3 are highlighted with an
atom-based color code (carbon, black; oxygen, red; nitrogen, blue), and hydrogen bonds are indicated as black dashed lines.
(C and D) Comparison of an Ig VH-VL heterodimer (PDB code 1MFA) (C) with a computer model of a pIgR D1 homodimer (D) created by
superimposing D1 on the VH and VL domains of a VH-VL heterodimer (C). The rmsd values are 1.39 A˚ for the VH-D1 superposition (calculated
for 101 C atoms) and 1.38 A˚ for the VL-D1 superposition (calculated for 78 C atoms). CDR3 loops are highlighted in pink.
Structure
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In addition to CDR1, mutagenesis and binding experi-
ments using rabbit pIgR have implicated the other CDRs
in binding dIgA. Replacing the CDR2 or CDR3 regions in
D1 with their corresponding regions from D2 results in
complete loss of dIgA binding (Coyne et al., 1994). The
human pIgR D1 structure reveals that CDR3 is posi-
tioned away from the other CDRs (Figure 2B), unlike the
CDR3 loops of Ig V domains, which form a contiguous
binding surface with CDRs 1 and 2 (Alzari et al., 1988).
It may therefore be difficult for a ligand contacting the
CDR1 and CDR2 regions of pIgR D1 to simultaneously
contact CDR3. Thus it is possible that the loss of affinity
upon replacing the D1 CDR3 with another sequence
may be due to steric interference with dIgA binding
rather than alteration of a direct binding surface. The
results of other loop replacements are harder to interpret
using the pIgR D1 structure: replacing the rabbit D1 EFFigure 5. Mutagenesis Data Mapped onto Structure
loop with its counterpart in D2 led to the loss of dIgAThe positions of substitutions that abolished (red) or decreased
binding, whereas replacing the C″D loop had little effect(blue) pIgA binding to rabbit pIgR (Coyne et al., 1994) are mapped
onto the human pIgR D1 structure. A close-up of the CDR1 region (Coyne et al., 1994). Both loops are on the opposite side
is shown in the upper right, and the sequence of CDR1 in human of the D1 domain from the CDRs (Figure 5), and are not
and rabbit pIgR D1 is shown in the lower right. Val29 (black), which expected to contact the ligand.
is solvent exposed in the D1 structure, was assumed to be buried
Although human pIgR binds both dIgA and pIgM, rab-and was therefore not substituted (Bakos et al., 1993; Coyne et al.,
bit pIgR only binds dIgA (Roe et al., 1999; Socken and1994).
Underdown, 1978). By taking advantage of these binding
differences, studies using site-directed mutants and hu-
gen bond with the main chain amino group of Gly95 in man/rabbit chimeric pIgR molecules have identified re-
the F strand. Human D1 Arg34 (rabbit Arg40) points in the gions required for binding pIgM (Roe et al., 1999). All
opposite direction from Arg31 and is occluded by the three CDR loops were shown to contribute to binding
CDR3 loop, forming a hydrogen bond to CDR3 loop pIgM, but to different extents. For maximal binding of
residue Asn97 (Figure 4B). Arg34 is thus unlikely to inter- rabbit pIgR to pIgM, replacing all three CDR loops with
act directly with a ligand, but may affect ligand binding their human counterparts was required, but CDR2 ap-
indirectly by stabilizing the CDR3 loop. This interpreta- pears to be the most critical: replacing rabbit CDR2
tion is consistent with the results of mutagenesis experi- with the human equivalent transferred pIgM binding,
ments involving rabbit pIgR in which replacing the rabbit and replacing human CDR2 with the rabbit sequence
counterpart of Arg34 with a glutamic acid, a residue that resulted in substantial loss of binding (Roe et al., 1999).
can still form a hydrogen bond with Asn97 in CDR3, had Sequence alignment shows large differences in the hu-
no affect on ligand binding, whereas substitution to an man and rabbit CDR2 loops, including a deletion of a
alanine, which cannot form the hydrogen bond, abol- charged residue, Glu54, in the rabbit CDR2 (Figure 3).
ished binding (Coyne et al., 1994). Lys35 (rabbit Lys41) Thus, deletion of the surface-exposed Glu54 may elimi-
is buried between the two  sheets and is also unlikely nate a point of electrostatic interaction between pIgR
to represent a direct point of contact with the antibody. and pIgM. Interestingly, only bovine and human pIgR
However, it stabilizes the position of the CDR1 loop by D1 regions contain the glutamic acid in their CDR2 loops
forming hydrogen bonds with Arg31 and Thr33 in the (Figure 3), and these are the only species of pIgR that
conserved helical turn in the CDR1 loop (Figure 5). Single show high affinity pIgM binding (Socken and Under-
point mutations in surrounding residues corresponding down, 1978).
to human pIgR residues Thr27, Ser28, Asn30, His32, and
Thr33 resulted in decreased dIgA binding (Coyne et al.,
1994). Residues Ser28 through His32 comprise the heli- The Human pIgR D1 Structure as a Model
for Similar Domainscal turn in CDR1 and, together with the adjacent Thr27
and Thr33, are surface exposed in positions that could Amino acid sequence alignment of pIgR D1 sequences
from eight different species reveals conservation of resi-interact with dIgA directly. The rabbit counterpart of
human D1 Val29 was not substituted because it was dues identified as critical for the human pIgR D1 struc-
ture (Figure 3), thus the human pIgR D1 structure canpredicted to be buried (Bakos et al., 1993; Coyne et al.,
1994), however, the crystal structure reveals that it is a be used as a first-order model for the D1 domains of
pIgR proteins from other species. In addition to the fivesurface-exposed residue located on the helix within the
CDR1 loop (Figure 5). Although its role in binding dIgA residues characteristic of Ig V domains (asterisks in Fig-
ure 3), the cysteines that participate in the second disul-is difficult to predict because it points in the opposite
direction from another critical residue, Arg31, solvent- fide bond and the three CDR loops (which are 67%–
100% conserved in CDR1, 50%–100% in CDR2, andexposed hydrophobic residues are often located at
binding interfaces (Dall’Acqua et al., 1996; Kelley and 40%–80% in CDR3), residues that participate in anchor-
ing the CDR1 and CDR3 loops are also highly conserved.O’Connell, 1993; Lebron and Bjorkman, 1999; Tsumoto
et al., 1995; Vaughn et al., 1997; Wells and de Vos, 1996). All of the residues comprising the helical turn in CDR1
Structure of a pIg Binding Fragment of pIgR
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are either conserved or conservatively substituted in all IgM, but not IgG, is expressed by the majority of B
lymphocytes and macrophages (McDonald et al., 2002;eight species, and Lys35, a buried residue that stabilizes
the helix, is also conserved (Figure 3). Tyr36, the residue Shibuya et al., 2000). Human pIgR D1 and the Ig-like
domain of Fc/R share 43% sequence identity. Theburied under the CDR3 loop (Figure 4B), is conserved
in 7 of 8 species of pIgR, and conservatively substituted five characteristic residues in Ig V domains (Figure 3)
and the second disulfide bond linking strands C and Cby a phenylalanine in the eighth species (rabbit) (Figure
3). Three other residues that interact to stabilize the are conserved between pIgR D1 and Fc/R, sug-
gesting similar tertiary structures. In addition, Fc/RCDR3 loop position are either conserved or conserva-
tively substituted in D1 sequences: CDR3 residue Asn97 shares 67% sequence identity with pIgR D1 in one of the
identified ligand binding sites, the CDR1 loop, including(a polar residue in all sequences), Arg34 (conserved),
and Thr48 (conserved) (Figure 3). Conservation of these complete conservation of all of the residues that com-
prise the helical turn within this loop in pIgR D1. Thecritical residues suggests that the helical turn in CDR1
and the unusual CDR3 location observed in the human unusual CDR3 position is potentially another feature
shared by the two proteins since the buried D1 residuespIgR D1 structure are preserved in other pIgR D1 do-
mains. The most notable difference in the D1 sequence Tyr36, Arg34, and Thr48 are conserved in Fc/R, and
D1 Asn97 is replaced by a glutamic acid. A hydrogenalignments is seen in the CC loop in all of the se-
quences. bond between Fc/R Glu97 and Thr48 (analogous to
the Asn97 to Thr48 hydrogen bond in pIgR D1) and aThe pIgR D1 structure can also be used to make pre-
dictions about the structures of the remaining domains salt bridge between Fc/R Glu97 and Arg34 (replacing
the hydrogen bond in pIgR D1 between Asn97 andin the human pIgR extracellular region. The characteris-
tic disulfide bond seen in members of the Ig superfamily Arg34) (Figure 4B) would preserve the downward orien-
tation of the CDR3 loop. The overall conservation of(Williams and Barclay, 1988) is retained in all five do-
mains. Also, pIgR domains 3, 4, and 5 each contain structurally important residues within the CDR loops
of Fc/R and pIgR D1 suggests a similar mode ofcysteines in positions to make the second disulfide bond
that bridges the C and C  strands of D1 (Figure 2C). interaction with the common ligands of these receptors.
Another IgA receptor, FcRI, shares an overlappingIn addition, D5 contains a third disulfide bond that re-
arranges as a result of the covalent association with binding site on the IgA Fc region with pIgR that includes
the FG loop of Fc (Herr et al., 2003a; Hexham et al.,dIgA, whereby Cys467 of pIgR is linked to Cys311 in
the IgA heavy chain (Fallgreen-Gebauer et al., 1993). 1999; White and Capra, 2002). The overlap of the binding
site has been suggested (Herr et al., 2003a) to explainThe characteristic salt-bridge in Ig-like domains, which
involves Arg63 and Asp86 in D1, is conserved in D2–D4, why secretory IgA (dIgA plus the pIgR ectodomain) can-
not bind to or activate FcRI in the absence of an integrinand the “invariant” tryptophan is present in D4 and D5
(Figure 3). By contrast with these conserved sequence coreceptor (van Egmond et al., 2000; Vidarsson et al.,
2001). Although pIgR and FcRI appear to recognize atfeatures, which suggest an overall similar folding topol-
ogy to that observed for the human D1 structure, the least some of the same portion of Fc, their structures
do not share detailed common features beyond the factthree CDR loops in human pIgR D1 do not share signifi-
cant sequence identity with their counterparts in D2–D5 that both molecules are Ig superfamily members. The
crystal structure of an FcRI/Fc complex shows that(Figure 3), suggesting local differences in loop struc-
tures. Such differences are not unexpected since the the site on FcRI at the interface with Fc involves
residues in the FcRI BC loop, the D strand, the DECDR loops are implicated in binding to dIgA, and only
D1 can bind to dIgA in isolation (Frutiger et al., 1986). loop, and the FG loop (Herr et al., 2003a). The BC and
FG loops in FcRI are topologically equivalent to CDR1Overall, the sequences of D2–D5 are more variable than
D1 across species (Piskurich et al., 1995). This observa- and CDR3, respectively, but are not technically CDRs
because FcRI does not resemble an Ig variable domain.tion is not surprising given the differences across spe-
cies that D2–D5 make to dIgA binding. In the case of Further, the two Ig-like domains of FcRI lack C″ strands
and therefore a loop equivalent to the CDR2 region.human pIgR, D2 and D3 enhance pIgR’s affinity for dIgA
(Norderhaug et al., 1999a). The presence of D2–D3 in Thus, although pIgR and FcRI bind to the same or to
an overlapping site on Fc, they do so with differentbovine pIgR also increases ligand binding affinity (Beale,
1988), but D2–D5 in rabbit pIgR do not contribute signifi- recognition modes and folding topologies. Further
cantly to dIgA binding (Frutiger et al., 1986). Thus, the structural studies of pIgR in complex with dimeric Fc
full-length ectodomain (D1–D5), an alternatively spliced will be required to compare the recognition properties
version (lacking D2–D3), and D1 of rabbit pIgR bind to of pIgR, Fc/R, and FcRI, and to fully understand the
pIgs with similar affinities (Deitcher and Mostov, 1986; mechanism by which pIgR is specific for the binding
Frutiger et al., 1986). Murine pIgR D2–D3 are not neces- and transport of polymeric Igs.
sary for high affinity noncovalent binding to dIgA (Crottet
and Corthesy, 1999), and chicken pIgR contains only Experimental Procedures
four extracellular Ig-like domains, with no ortholog to
Protein Expression and PurificationD2 of mammalian pIgRs (Wieland et al., 2004).
The cDNA encoding the full-length human pIgR was kindly providedSequence alignment suggests that human pIgR D1
by Roland Strong (Fred Hutchinson Cancer Research Center, Seat-also shares structural similarities with the corresponding
tle, WA). For bacterial expression, pIgR D1 (encoding residues Lys1–
region of another IgA and IgM receptor, the Fc/ recep- Val109) was subcloned into the pET20b expression vector (Novagen)
tor (Fc/R) (Figure 3) (Shibuya et al., 2000). Fc/R, in frame with the C-terminal 6His tag using the following primers:
5-G GAA TCC CAT ATG AAG AGT CCC ATA TTT GGT CC-3 andwhich can bind to monomeric and polymeric IgA and
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Table 1. Data Collection, Phasing, and Refinement Statistics for pIgR D1
No. Unique
Reflections/Total Twin Phasing
Data Set Wavelength (A˚) Resolution (A˚) Reflections Completeness (%)a Fraction (%) Rmerge (%)b I/ Powerc
Native I 1.54 2.5 (2.59–2.50) 21,524/76,172 97.4 (80.7) 26.5 8.5 (34.3) 19.6 (2.5)
Native II 1.078 1.9 (1.93–1.90) 49,755/185,798 99.6 (99.1) 37.3 7.8 (46.2) 17.7 (2.6)
PIP 1.54 3.2 (3.31–3.20) 10,464/28,678 98.5 (94.3) 20.7 9.7 (20.8) 11.3 (5.3) 0.4
Gd 1.7108 2.8 (2.85–2.80) 27,967/47,501 89.6 (58.7) 30.3 10.4 (41.3) 8.6 (1.5) 1.0
Pb 0.9509 2.0 (2.03–2.00) 79,649/153,910 94.1 (92.7) 37.0 6.5 (23.8) 12.2 (3.5) 0.6
Refinement Statistics (P21) Number of Nonhydrogen Atoms
Resolution (A˚) 30–1.9 Protein 4993
Number of reflections in working set 47,117 (93.4%) Water 158
Number of reflections in test set 2,476 (4.9%) Mg2	 2
Rcryst (%)d 18.3
Rfree (%)e 24.4
Ramachandran plot quality (%)
Nonglycine residues in
most favored 87.3
Rmsd from ideality additionally allowed 12.3
Bond lengths (A˚) 0.007 generously allowed 0.4
Bond angles (deg) 1.30 disallowed 0.0
Values in parentheses indicate data in the highest resolution shell.
a Completeness is defined as the number of independent reflections/total theoretical number.
b Rmerge 
 100  (|I  I|)/I, where I is the integrated intensity of a given reflection.
cRms fh/E (phasing power), where fh is the heavy atom structure factor amplitude and E is the lack of closure error. The phasing power statistics
were derived using twinned data and may therefore not be accurate.
d Rcryst(F) 
 h||Fobs(h)|  |Fcalc(h)||/h|Fobs(h)|, where |Fobs(h)| and |Fcalc(h)| are the observed and calculated structure factor amplitudes for the hkl
reflection.
e Rfree is calculated from reflections in a test set not included in the atomic refinement.
5-GG AAT TCA CTC GAG GAC CTC CAG GCT GAC-3. The protein Protein concentrations were determined spectrophotometrically
at 280 nm using extinction coefficients of 13,370 M1cm1 for pIgRwas expressed in E. coli BL21(DE3) cells (Novagen) by induction at
OD600 
 0.5  0.6 with isopropyl--D-thiogalactoside (IPTG) at a D1 and 64,940 M1cm1 for monomeric Fc and Fc-tp, calculated
from their amino acid sequences using the ProtParam tool on thefinal concentration of 0.4 mM for 5 hr at 37C. pIgR D1 inclusion
bodies were solubilized in 8 M guanidine-HCl and 10 mM DTT. The ExPASy Proteomics Server (Gill and von Hippel, 1989).
protein was refolded by the rapid dilution method in refolding buffer
(100 mM Tris [pH 8.0], 400 mM L-arginine, 2 mM EDTA, 0.5 mM
oxidized glutathione, and 5 mM reduced glutathione) (Garboczi et Binding Studies
Surface plasmon resonance (SPR) biosensor assays were carriedal., 1992). The refolded protein was concentrated in a stirred-cell
pressurized concentrator (Amicon) and loaded onto a Superdex 75 out using a BIAcore 2000 instrument (Pharmacia Biosensor, Upp-
sala, Sweden). In this system, binding between a molecule coupled26/60 column (Amersham Biosciences) for size exclusion chroma-
tography. to a biosensor chip (the “ligand”) and a second molecule injected
over the chip (the “analyte”) results in changes in the SPR signalFor insect cell expression to produce glycosylated protein, pIgR
D1 containing a C-terminal 6His tag was subcloned into the bacu- that are read out in real time as resonance units (RUs) (Malmqvist,
1993). dIgA was covalently coupled to a reagent-grade CM5 sensorlovirus transfer vector pAcGP67A (BD Biosciences) in frame with
the gp67 secretion signal. Recombinant baculovirus was generated chip (Biacore) at three different densities (412, 763, and 1426 RUs)
using the primary amine coupling method described in the BIAcoreby cotransfection of the transfer vector with linearized viral DNA
(Baculogold; BD Biosciences). pIgR D1 was harvested from the manual. The first flow cell was mock coupled with buffer only for
background subtraction. A 2-fold dilution concentration series (fromsupernatant of baculovirus infected High 5 insect cells, which was
concentrated and buffer exchanged into TBS (20 mM Tris [pH 8.0], 10.24 M to 20 nM glycosylated D1 or from 6.4 M to 12.5 nM
nonglycosylated D1) of 180 l of pIgR D1 (the analyte) was injected150 mM NaCl) and purified by Ni-NTA affinity followed by size exclu-
sion chromatography on a Superdex 200 16/60 column (Amersham over the chip at 5 l/min in 50 mM HEPES (pH 8.0), 150 mM NaCl,
and 0.005% (v/v) P20, and the binding reactions were allowed toBiosciences).
Human pIgA isolated from the sera of a patient with a pIgA- closely approach or to reach equilibrium. Two-minute injections of
1.5 M MgCl2 were used to regenerate the surface of the chip betweenproducing myeloma was kindly provided by Jean-Pierre Vaerman
(Catholic University of Louvain, Brussels, Belgium) (Song et al., 1995; injections. The sensorgrams were processed and analyzed with the
Scrubber software package (BioLogic Software, Campbell, Austra-Vaerman et al., 1995). pIgA was further purified by size exclusion
chromatography on a Superdex 200 HR 10/30 column (Amersham lia). Equilibrium dissociation constants (KDs) were derived by nonlin-
ear regression analysis of plots of Req (the equilibrium binding re-Biosciences) to separate dIgA from higher order polymers. The peak
corresponding to dIgA (two IgA molecules linked by J-chain) was sponse) versus the log of the concentration of analyte, and the
resulting binding data were fit to a single-site binding model. Dataused for the binding studies. Soluble FcRI and monomeric Fc
(Fc homodimers lacking a tailpiece that are not linked by J-chain) collection and binding analyses were performed identically for the
glycosylated and nonglycosylated forms of pIgR D1. To comparewas purified from the supernatants of stably transfected Chinese
hamster ovary (CHO) cells as described previously (Herr et al., the binding of pIgR D1 to monomeric and dimeric versions of the
Fc region of IgA, Fc, Fc-tp, and dIgA were coupled to a CM52003b). Monomeric Fc with the 18 residue tailpiece (Fc-tp) and
an N-terminal 6His tag was generated and purified as described biosensor chip at densities of 2457 RUs, 1411 RUs, and 3153 RUs,
respectively, as described above. 100 l of 5 M glycosylated D1,for Fc (Herr et al., 2003b).
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nonglycosylated D1, or FcRI were injected over the chip at 50 lated to 2.7 A˚ and solvent flattened with Solomon (CCP4, 1994). The
l/min in 50 mM HEPES (pH 8.0), 150 mM NaCl, 0.005% (v/v) P20. first four molecules in the asymmetric unit were located in the initial
experimental map using the program MOLREP (Vagin and Teplya-
kov, 1997) and a “ strands-only” model of NKp44 (PDB code 1HKF)Crystal Growth and Data Collection
(Cantoni et al., 2003) (nonconserved side chains truncated to alanineCrystals were grown by vapor diffusion in 1:1 hanging drops con-
and residues 5–9, 14–15, 25–31, 40–45, 53–55, 69–71, 80–85, 95–101,taining bacterially-expressed pIgR D1 (10 mg/mL in 20 mM HEPES
and 112 omitted). The remaining two molecules were located using(pH 7.0), 150 mM NaCl), 20% (w/v) polyethylene glycol 8000 (PEG
the real space search program ESSENS (Kleywegt and Jones, 1997).8000), 0.2 M magnesium acetate tetrahydrate, and 0.1 M sodium
Maps were calculated by solvent flattening and histogram matchingcacodylate (pH 6.5) and reproduced by streak seeding. Before data
with DM in CCP4 (CCP4, 1994). NKp44 (Cantoni et al., 2003) servedcollection, crystals were cryopreserved in 23% (w/v) PEG 8000, 0.2
as a starting point for model building with the program O (JonesM magnesium acetate tetrahydrate, and 0.1 M sodium cacodylate
and Kjeldgaard, 1997).(pH 6.5) with 15% (v/v) glycerol. Heavy atom derivatives were pre-
Refinement was performed using the CNS suite of programspared by soaking crystals in the following solutions: 1 mM di--
(Brunger et al., 1998). The test set of reflections for calculating Rfreeiodobis (ethylenediamine) diplatinum (II) nitrate (PIP), 40 mM tri-
methyl lead acetate, or 100 mM gadolinium (III) chloride. Data from was generated with the thin shell method in DATAMAN (Kleywegt
a native crystal and the PIP derivative were collected at 170C and Jones, 1996) to minimize the bias from the 6-fold noncrystallo-
using an R-AXIS IV mounted on a Rigaku RU-200 rotating anode graphic symmetry (NCS) and twin-related reflections. Initial refine-
generator. This native data set (native I) was used for initial phase ment was conducted using the 2.5 A˚ native I data with NCS con-
determination and model building. A higher resolution native data straints, grouped temperature (B) factors, bulk solvent and
set (native II), which was used for refinement, and the lead and anisotropic temperature-factor corrections. In subsequent refine-
gadolinium derivative data sets were collected on beamline 8.2.2 at ment using the 1.9 A˚ native II data set, the NCS constraints were
the Advanced Light Source (ALS, Berkeley, CA) at170C (Table 1). relaxed to NCS restraints (300 kcal/mol A˚2) and individual B factors
were calculated, taking into account the twin fraction of 37.3% and
Structure Determination and Refinement maintaining the same set of test reflections for calculating Rfree. NCS
Data were processed and scaled with DENZO and SCALEPACK restraints were limited to the main chain atoms of the  strands,
(Otwinowski and Minor, 1997). The data could be indexed in either excluding regions that differed in the six molecules (mostly at crystal
primitive monoclinic (P21) or C-centered orthorhombic (C2221) space contacts and in the loops). Rcryst and Rfree improved by 5.1% and
groups with unit-cell parameters a
 42.1 A˚, b
 156.4 A˚, c
 53.9 A˚; 3.4%, respectively, after inclusion of the corrections for twinning.
 
 113.0 or a 
 42.1 A˚, b 
 99.2 A˚, and c 
 156.4 A˚, respectively. The final model (Rcryst 
 18.3%, Rfree 
 24.4%) contains six D1
The overall scaling statistics for C2221 were significantly worse than domains (residues 2–109) arranged as three dimers, five or six resi-
for P21 (Rsym 
 14.3% [47.7%] versus Rsym 
 8.5% [34.3%]) and the dues of the C-terminal 6His tag in two of the six D1 domains
h0l plane did not show mm symmetry, indicating the crystals were (molecules B and A, respectively), 158 water molecules, and two
monoclinic. After examination of systematic absences in the 0k0 Mg2	 ions. Each of the two Mg2	 ions are coordinated by three
reflections, the space group was assigned as P21. The asymmetric histidine residues in the 6His tags from two molecules (His112
unit contains six molecules with a solvent content of 40% (VM 
 and His115 from molecule A with His112 from molecule F coordinate
2.1 A˚3/Da) as calculated from the Matthews coefficient (Matthews, one ion and His112 and His115 from molecule B with His112 from
1968). molecule E from the adjacent asymmetric unit coordinate the other).
For merging the native and derivative data sets, two options for Residue 2 in molecules B, C, and D; the CC loop (residues 41–45)
indexing had to be considered. Two identical but nonequivalent unit in molecules A, B, C, and D; and the 6His tag for molecules C, D,
cells can be defined in monoclinic space groups when cos 
 E, and F were disordered and are not included in the refined model,
a/(2c) (Rudolph et al., 2004), a condition met by the D1 unit cell and 2.8% of the residues were modeled as alanine. The electron
parameters. Each derivative data set was compared to two versions density is weak for residues 97–101 (with B factors averaging 49.6 A˚2,
of the native I data set: as originally indexed, and reindexed using
compared with an average of 32.3 A˚2 for the rest of the model).
the transformation (h, k, l) to (h, k, hl). The correct indexing of
Ramachandran plot statistics were calculated using PROCHECK
each derivative as compared to the native I data was determined
(Laskowski et al., 1993). Automated structural comparisons of pIgR
by comparing Rmerge values, which were systematically higher when D1 were done using the DALI server (Holm and Sander, 1993). Least-
the opposite indexing had been chosen for the two data sets being
squares alignments of pIgR D1 and its closest structural homolog,compared (Tucker et al., 1996).
the VL and VH domains of a mouse scFv (PDB code 1MFA), wereIn addition to indexing ambiguities, the D1 diffraction data exhib-
done using O (Jones and Kjeldgaard, 1997). Sequence alignmentsited evidence of pseudomerohedral twinning, a rare type of twinning
were performed with T-Coffee (Notredame et al., 2000). Figures werethat can occur in monoclinic and orthorhombic crystal systems
generated with Molscript (Kraulis, 1991), Bobscript (Esnouf, 1997),when the unit cell parameters meet certain conditions (Rudolph et
and Raster 3D (Merrit and Murphy, 1994).al., 2004). One such condition, as discussed above, is when
cos 
 a/(2c), in which case twinned crystals in the monoclinic
system can mimic an orthorhombic space group. Since the D1 crys-
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